Fifteen minutes, no downtime. Two or three days later, the 11s between your brows start to ease — and you still look like you, with every smile and lift intact.
You come in, we map the two small muscles that pull your brows into a knot, and a few micro-injections later you're out the door — about fifteen minutes, no bruising plan, no recovery day.
By day two or three the crease starts to soften. By day seven to fourteen it's gone — but your forehead still moves, your smile still reaches your eyes. The effect rides for three to four months, then gently fades.
Letybo is the newest neurotoxin on the U.S. market — FDA-approved in 2024 and already one of the most-used in the world. A clean, modern choice if you're starting out, or if you want to try something fresh alongside what you already know.
Treated areas · Glabella (11s) · Forehead · Crow's feet · Brow lift · Lip flip · Jawline · Neck bands
Where it fits.
Three things patients tell us over and over after their first Letybo visit — and why they come back.
That vertical crease that makes you look tired or worried — softened where it forms, the small muscles that pull your brows together quietly let go.
Conservatively dosed and mapped to your face — not a template. You'll laugh, frown, raise an eyebrow. The line goes; the expression stays.
Approved in 2024 and already one of the most-used neurotoxins worldwide — a current option if you've plateaued on what you've been using.
Same active molecule, same family. Dysport has a 15-year on-shelf record and the widest range of off-label refinement we reach for. Letybo is the newest U.S.-cleared option and the most narrowly indicated — we use it almost exclusively on label, where its glabellar evidence is excellent.
The questions that come up most often when someone is trying Letybo for the first time — or thinking about switching from what they've been using.
Most patients notice the first softening around day two or three. The full effect lands between day seven and fourteen — that's when we ask you to come back if anything still needs a touch.
No — and that's the entire point of how we dose. We map the two small muscles that pull your brows into a knot, treat only what's pulling, and leave the rest of your face to do what it does. You should still raise an eyebrow, frown, and have your smile reach your eyes.
It's the same drug family — botulinum toxin type A — with a slightly different formulation. Letybo is the newest on the U.S. market, FDA-approved in 2024 after years of use abroad. Onset and duration sit right in the same range as Botox. The choice usually comes down to what your face has responded to historically and what feels right for this season.
Yes — and many of our patients do, just to see. We'll take a careful history of what dose you've been on, how long it's been lasting, and whether you've noticed any drift. Switching is straightforward; the only reason to wait is if your last round hasn't worn off yet.
Around three to four months, the line returns gradually — no sudden snap-back. Most patients schedule the next visit when they first start to see movement creeping back, which lands at three or four visits a year.
Botulinum toxin type A has one of the longest aesthetic safety records of any injectable — decades of use, hundreds of millions of treatments worldwide. Letybo specifically was in wide clinical use abroad for years before the FDA cleared it here. Side effects are usually localized and short-lived; we'll walk through your specific picture at the consult.
Letybo treatments begin with an unhurried conversation — your anatomy, your expression, and how lightly the touch should land.
Plus: how we’d use a summer with the schedule on your side. One page, refreshed each month.
Read this month →